Koyfin Home > Directory > Health Care > Aldeyra Therapeu > EBIT

Aldeyra Therapeu EBIT Chart (ALDX)

Aldeyra Therapeu annual/quarterly EBIT from 2012 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Aldeyra Therapeu EBIT for the quarter ending June 06, 2020 was $-7m a -168.27% increase of 12m year over year
  • Aldeyra Therapeu EBIT for the last 12 months ending June 06, 2020 was $-49m a -12.62% increase of 6m year over year
  • Aldeyra Therapeu Annual EBIT for 2019 was $-57m a 29.74% decrease of -17m from 2018
  • Aldeyra Therapeu Annual EBIT for 2018 was $-40m a 43.35% decrease of -17m from 2017
  • Aldeyra Therapeu Annual EBIT for 2017 was $-22m a 16.86% decrease of -4m from 2016
Other Income Statement Metrics:
  • Aldeyra Therapeu EBITDA for the quarter ending December 12, 2018 was $-11m a 23.44% decrease of -3m year over year
  • Aldeyra Therapeu Net Income for the quarter ending September 09, 2018 was $-11m a 35.68% decrease of -4m year over year
View Chart On Koyfin

Quarterly ALDX EBIT Data

06/2020$-7m
03/2020$-10m
12/2019$-13m
09/2019$-19m
06/2019$-14m
03/2019$-11m
12/2018$-11m
09/2018$-11m
06/2018$-9m
03/2018$-8m

Annual ALDX EBIT Data

2019$-57m
2018$-40m
2017$-22m
2016$-19m
2015$-12m
2014$-7m
2013$-4m
2012$-1m
2011$-2m